Neuroprotection: is it already applicable to glaucoma therapy?

Area of Science:

• Neuroscience
• Ophthalmology
• Pharmacology

Background:

• Neuroprotection involves safeguarding neurons from damage, a critical factor in managing neurodegenerative diseases like glaucoma.
• Numerous natural and synthetic compounds, including antioxidants and receptor antagonists, exhibit neuroprotective properties.
• Current limitations in the availability of specific neuroprotectants and a lack of clinical trials hinder their application in glaucoma treatment.

Purpose of the Study:

• To provide an overview of neuroprotection in the context of glaucoma.
• To identify and suggest easily available compounds with potential neuroprotective activity for glaucoma.

Main Methods:

• Literature review of existing neuroprotective compounds and their mechanisms.
• Analysis of compound availability and relevance to glaucoma treatment.

Main Results:

• A wide array of compounds, such as N-methyl-D-aspartate receptor antagonists and cannabinoids, demonstrate neuroprotective effects.
• Key barriers to clinical use include limited availability in the US and insufficient clinical trial data for glaucoma.

Conclusions:

• Easily accessible compounds may offer viable neuroprotective strategies for glaucoma.
• Further research and clinical trials are needed to validate the efficacy of readily available neuroprotective agents for glaucoma.